Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
about
Ribosomal Antibiotics: Contemporary ChallengesMolecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptideMacrolide Resistance in Streptococcus pneumoniaeDeletion of L4 domains reveals insights into the importance of ribosomal protein extensions in eukaryotic ribosome assembly.Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome.CFTR and lung homeostasis.Impact of P-Site tRNA and antibiotics on ribosome mediated protein folding: studies using the Escherichia coli ribosomeMicroscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries.In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatmentA comprehensive review of glycosylated bacterial natural products.New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.Interactions of the TnaC nascent peptide with rRNA in the exit tunnel enable the ribosome to respond to free tryptophan.Purification, characterization and crystallization of the human 80S ribosome.Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis.Elements of ribosomal drug resistance and specificity.Anti-infective properties of bacteriocins: an update.The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.Toward the rational design of macrolide antibiotics to combat resistance.Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin.Bacterial Protein Synthesis as a Target for Antibiotic Inhibition.Resistance to Macrolide Antibiotics in Public Health Pathogens.Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesisSequence-dependent elongation dynamics on macrolide-bound ribosomes.The macrolide antibiotic renaissance.New treatment options for lower respiratory tract infections.Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin.In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.Phylogeny-driven target selection for large-scale genome-sequencing (and other) projects.Structural insights into substrate selectivity of ribosomal RNA methyltransferase RlmCD.Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than othersRlmCD-mediated U747 methylation promotes efficient G748 methylation by methyltransferase RlmAII in 23S rRNA in Streptococcus pneumoniae; interplay between two rRNA methylations responsible for telithromycin susceptibility.Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents.Parametrization of macrolide antibiotics using the force field toolkit.Ribosome protection by antibiotic resistance ATP-binding cassette protein.
P2860
Q26745532-679BDB5E-9EFB-4D62-BFC5-2DC8529740F1Q27682411-E58F859E-66A3-48A6-BA3D-EE44FA3C91C4Q28070243-B6F8361A-64FE-4111-BFDE-F05DA1F082B2Q34363886-B50798A1-E256-4429-AE82-2E96F8B0FDA7Q34576226-82528487-DB07-4897-AE10-1A820E847436Q34726856-AF8B9066-F9A1-4C13-B8ED-6912D36D603FQ35202470-7BDE7691-21AC-4418-9B4E-10CC6A1D9859Q35683997-D3579BC3-87CD-479E-9E1E-8FF5D84B98ADQ35960910-EF46AFED-8B38-4AC3-AF22-E1DF68B41C91Q36029831-576AE79A-787A-431E-ACDD-907D0967CFC8Q36153263-52C8BC25-33AA-49F1-A30F-A39E66CF1A8CQ36667110-E679F926-068F-466B-AA33-8A484CE5CFFFQ36923902-EE191FE2-57D6-4364-AE3E-133AE6965657Q37518622-C6EE6123-9540-4F32-AEC3-1977D104F778Q37680347-69E86BAC-0766-4F84-8074-5179420AFFFCQ37713726-20E14220-B97E-490D-A460-A66D286CC156Q38043799-EDF85862-3F91-4B6A-BF64-188B943BF359Q38056436-0E678E02-FDBF-45DB-926E-F78B523F0D39Q38217504-039CCD98-6A7D-4FA1-B848-C192BD5DAA12Q38728783-16974975-0EF1-499B-A6F0-97DF5EB0F707Q38804355-1C924EA6-53E4-4EE3-8CBA-86B3166E8792Q38915765-9F943C6A-C1FF-4A70-AFAB-8F1D8164A030Q38928353-16D774BA-0B5F-4F28-9AF4-4BDBDBB9BB99Q39026738-B7236163-4924-4469-AA5C-6041D9F78463Q39172960-D4BE43C0-A0AB-4F83-91C5-360E0B2B1242Q39321104-09579464-FEAF-4A24-8265-30D4AD77BDA8Q39325572-D3B86733-D611-42AC-BFCE-9E00B35496FFQ39406507-906CF802-3E1F-4AE9-84B1-2A6D8836405CQ40111519-7AF099F9-148D-4FAC-8622-F4A2AE0ACC7BQ40367841-F9A4218E-B542-44DB-B203-7DF5749C5ED0Q40377312-6B13B3AA-8798-467C-BFC4-404A32568480Q41791211-1B824E3B-7DFD-4F98-A144-054A1B4A14A4Q41956115-48E54819-2697-45FD-B6E1-9DEBFA8DAF1DQ42364343-E62779DF-E0D9-4AF1-89E4-3B438433F6DDQ42428577-3F3ABA54-FDAC-41E3-BD5F-D138695A6C88Q42592473-1DAAAEB9-66BF-489B-A605-6C134445D3B3Q43079964-6CE262A8-E3E0-490E-BF1E-990D62CF189EQ43245954-2B03A251-C763-4E1C-AFAB-383F208AB997Q53689783-942C9CF9-B1FF-474B-ADB4-4DBF01FF84DE
P2860
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@en
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@nl
type
label
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@en
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@nl
prefLabel
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@en
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@nl
P2860
P1476
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
@en
P2093
Alexander S Mankin
P2860
P356
10.1111/J.1749-6632.2011.06315.X
P407
P577
2011-12-01T00:00:00Z